Abstract
Development of quantification methods of a new selective carbonic anhydrase II inhibitor in plasma and blood and study of the pharmacokinetics of its ophthalmic suspension in rats
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have